Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

    Funding opportunity for HIV/AIDS research aligned with NIDDK's mission and NIH priorities.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000

    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

    This grant aims to support innovative research on the intersection of HIV and substance use, with the goal of advancing prevention, treatment, and cure efforts among people who use drugs. It is open to both individuals and research teams, covering a wide range of research areas.

    HHS-NIH11Due Feb 5, 2027$7,500,000

    Implementation and Evaluation of Databases to Examine AIDS

    NIH supports a research consortium integrating real-world data and advanced analytics to study HIV outcomes and evaluate strategies to improve prevention, treatment, and care.

    HHS-NIH11Forecasted May 27, 2027Forecasted

    Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

    Supports high-risk, high-impact research on HIV and substance use to advance HIV prevention, diagnosis, treatment, and virus suppression among people who use substances or have substance use disorders.

    HHS-NIH11Due Sep 25, 2027$3,500,000